₹0.61
■ +0 +0.00%
17 Jul 2026
BSE Listed
Yamini Investments Compan (511012)
Volume: 4,14,260Avg Vol 1W: 4,33,955Avg Vol 1M: 4,26,59052W Range:₹0.6₹1.16
Key Ratios
Checked just nowMarket Cap₹32 Cr
Current Price₹0.61
Previous Close₹0.61
High / Low (52w)₹1.16 / ₹0.6
Volume4,14,260
Avg Vol (1W)4,33,955
Avg Vol (1M)4,26,590
Stock P/E—
Book Value₹1.32
Dividend Yield0%
ROE26.91%
ROA22.7%
Revenue (TTM)—
Revenue Growth—
Profit Margin290.52%
Total Debt—
Shares Outstanding53 Cr
Face Value—
EPS (TTM)₹0
P/B0.46
Debt / Equity0.14
50 DMA₹0.65
200 DMA₹0.72
Day change+0.00%
Price Chart
₹0.61▼ 47.41% · 1Y
2025-07-172026-07-16
20-day avg volume: 4.2L shares
Pros
- Healthy return on equity of 26.9%.
- Company is almost debt-free.
- Revenue grew 373% YoY.
- Net profit is growing year over year.
- Stock trades below its book value.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Profit | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹-3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹10 Cr | ₹47 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹67 Cr | ₹68 Cr | ₹68 Cr | ₹68 Cr | ₹68 Cr | ₹70 Cr | ₹70 Cr | ₹91 Cr |
| Total Liabilities | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹22 Cr |
| Equity | ₹67 Cr | ₹67 Cr | ₹67 Cr | ₹67 Cr | ₹67 Cr | ₹67 Cr | ₹68 Cr | ₹69 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹-4 Cr | ₹-4 Cr | ₹0 Cr | ₹9 Cr | ₹7 Cr |
| Investing | ₹5 Cr | ₹4 Cr | ₹0 Cr | ₹-8 Cr | ₹-6 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹-4 Cr | ₹-4 Cr | ₹0 Cr | ₹9 Cr | ₹7 Cr |
Shareholding
Promoter 1.78% Institutions 0.04% Public 98.19%
Efficiency & Working Capital
ROCE0.4%
Interest Coverage3.1
Dividend Payout—
Debtor Days83 d
Inventory Days188 d
Payable Days20 d
Cash Conversion Cycle252 d
Working Capital Days272 d
Shareholding Details
As of 2026-03-31
Promoter1.8%
FII0%
DII0%
Institutions0%
Public98.2%
Promoter Pledge0%
No. of Shareholders2,33,578
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% | 1.8% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% | 98.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,27,529 | 1,35,662 | 1,47,634 | 1,64,135 | 1,87,104 | 2,24,073 | 2,45,225 | 2,44,739 | 2,41,930 | 2,40,399 | 2,37,171 | 2,33,578 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Manlike Chemical And Pharmaceutical Company Private Limited | Public Shareholding | 3.9% | 2.04 Cr |
| Madhur Buildcon Private Limited | Shareholding of Promoter and Promoter Group | 1.7% | 89,60,000 |
| Duxton Hills Builder Private Limited | Public Shareholding | 1.1% | 55,71,704 |
| Vandana Agarwal | Shareholding of Promoter and Promoter Group | 0.1% | 2,85,500 |
| Surbhi Infraproject Private Limited | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Vandana Agarwal | 0 | 0% | 2026-03-31 |
| Madhur Buildcon Private Limited | 0 | 0% | 2026-03-31 |
| Surbhi Infraproject Private Limited | 0 | 0% | 2026-03-31 |
| Manlike Chemical And Pharmaceutical Company Private Limited | 0 | 0% | 2026-03-31 |
| Duxton Hills Builder Private Limited | 0 | 0% | 2026-03-31 |
| Vandana Agarwal | 0 | 0% | 2025-09-30 |
| Madhur Buildcon Private Limited | 0 | 0% | 2025-09-30 |
| Surbhi Infraproject Private Limited | 0 | 0% | 2025-09-30 |
| Manlike Chemical And Pharmaceutical Company Private Limited | 0 | 0% | 2025-09-30 |
| Duxton Hills Builder Private Limited | 0 | 0% | 2025-09-30 |
| Vandana Agarwal | 0 | 0% | 2025-06-30 |
| Madhur Buildcon Private Limited | 0 | 0% | 2025-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Manish Dalmia | Executive Director & MD | 2025 |
| Rubi Nandi | Executive Director | 2025 |
| Vandana Agarwal | Executive Director | 2025 |
| Satanand Pandey | Independent Director | 2025 |
| Girish Verma | Independent Director | 2025 |
| Priti Rao | Independent Director | 2025 |
| Kalpana Agarwala | Company Secretary | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 102 | 53 | 53 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
9 disclosure(s)
Market04/02/2022 · 54,86,194
Market03/02/2022 · 50,00,000
Market03/02/2022 · 50,00,000
Market27/01/2022 · 5,66,510
Market25/01/2022 · 10,90,915
Market30/12/2021 · 1,00,00,000
Company Information
🌐 www.yaminiinvestments.com ↗
📍 D-215 Cystal Plaza New Link, Board Andheri West, Mumbai, Maharashtra, 400053
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search